A Super Bowl commercial put out by the telehealth company Hims & Hers is drawing heat from critics who say the company's promotion of its weight-loss drugs misled consumers by leaving out key ...

D uring the Super Bowl, Hims & Hers Health aired a commercial called “Sick of the System.” But before the 60-second spot was played on Fox Sunday night, the ad — which deems obesity ...

(Hims & Hers Health) Telehealth provider Hims & Hers Health is defending its Super Bowl ad, which is styled as a political manifesto against weight-loss treatments priced “for profits ...

The GLP-1 wars are heating up. After telehealth brand Hims & Hers aired its first Super Bowl commercial Sunday night, competitor Novo Nordisk, which makes competing weight loss drugs Ozempic and ...

Hims & Hers’ decision to advertise at the Super Bowl — where 30-second slots have sold for at least $7 million each — represents an ambitious play for the brand as it positions itself in the heart of ...

Hims & Hers saw a massive YTD surge, but FDA news led to a pullback. Find out why HIMS stock is still undervalued and why acquisitions boost its outlook.

Earlier in February, Hims & Hers Health rallied as it was set to debut its controversial Super Bowl ad, where it positioned itself as the “affordable, doctor-trusted, formulated in the US ...

The FDA said the shortage of Novo Nordisk's weight-loss drugs Wegovy and Ozempic is resolved. The move could limit cheaper compounded versions ...

With the FDA shutting down its key revenue stream, Hims faces a tough road ahead--can it justify its valuation?

Hims & Hers' lower-priced injectable semaglutide promoted during the Super Bowl has led to some patients receiving the more ...